CQUniversity
Browse

Increased calcium influx mediates increased cardiac stiffness in hyperthyroid rats

journal contribution
posted on 2017-12-06, 00:00 authored by S Levick, L Brown, Andrew FenningAndrew Fenning
Cardiac remodeling (hypertrophy and fibrosis) and an increased left ventricular diastolic stiffness characterize models of hypertension such as the SHR and DOCA-salt hypertensive rats. By contrast, hyperthyroidism induces hypertrophy and hypertension, yet collagen expression and deposition is unchanged or decreased, whereas diastolic stiffness is increased. We determined the possible role of increased calcium influx in the development of increased diastolic stiffness in hyperthyroidism by administering verapamil (15 mg/[kg·d] orally) to rats given triiodothyronine (T3) (0.5 mg/[kg·d] subcutaneously for 14 d). Administration of T3 significantly increased body temperature (control: 36.7 ± 0.2°C; T3: 39.6 ± 0.2°C), left ventricular wet weight (control: 2.09 ± 0.02 mg/kg; T3 3.07 ± 0.07 mg/kg), systolic blood pressure (control: 128 ± 5 mmHg; T3: 156 ± 4 mmHg), and left ventricular diastolic stiffness (control: 20.6 ± 2.0; T3: 28.8 ± 1.4). Collagen content of the left ventricle was unchanged. Contractile response to noradrenaline in thoracic aortic rings was reduced. Relaxation in response to acetylcholine (ACh) was also reduced in T3- reated rats, whereas sodium nitroprusside response was unchanged. Verapamil treatment of hyperthyroid rats completely prevented the increased diastolic stiffness and systolic blood pressure while attenuating the increased body temperature and left ventricular weight; collagen content remained unchanged. ACh response in thoracic aortic rings was restored by verapamil. Thus, in hyperthyroid rats, an increased calcium influx is a potential mediator of the increased diastolic stiffness independent of changes in collagen.

Funding

Category 1 - Australian Competitive Grants (this includes ARC, NHMRC)

History

Volume

43

Issue

1

Start Page

53

End Page

60

Number of Pages

8

ISSN

1085-9195

Location

United States

Publisher

Humana Press, Inc.

Language

en-aus

Peer Reviewed

  • Yes

Open Access

  • No

Era Eligible

  • Yes

Journal

Cell biochemistry and biophysics.